GLP-1 Receptor Agonists Slow Epigenetic Aging, a Measure of the Harms Done by Excess Visceral Fat (opens in new tab)

Weight loss drugs are a major focus of the pharmaceutical industry at present. It remains to be seen as to what will emerge as the next big class of weight loss drugs following GLP-1 receptor agonists. Since the primary effect of GLP-1 receptor agonist drugs is a reduction in calorie intake, all of the gathered data in humans is really just a sizable confirmation of the harms done by the presence of excess visceral fat tissue, and the benefits gained from losing that fat via dieting. It would...